FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

724144006: Embryofetopathy caused by methimazole (disorder)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3431096018 Embryofetopathy caused by methimazole (disorder) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3431097010 Methimazole embryofetopathy en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3431098017 Embryofetopathy caused by methimazole en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3431099013 A teratogenic embryofetopathy that results from maternal exposition to methimazole in the first trimester of pregnancy. Methimazole is an antithyroid thionamide drug used for the treatment of Graves' disease. In the infant, methimazole may result in choanal atresia, esophageal atresia, omphalocele, omphalomesenteric duct anomalies, congenital heart disease (such as ventricular septal defect), renal system malformations and aplasia cutis. Additional features that may be observed include facial dysmorphism (short up slanting palpebral fissures, a broad nasal bridge with a small nose and a broad forehead) and athelia. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
3431100017 A teratogenic embryofetopathy that results from maternal exposition to methimazole in the first trimester of pregnancy. Methimazole is an antithyroid thionamide drug used for the treatment of Graves' disease. In the infant, methimazole may result in choanal atresia, oesophageal atresia, omphalocele, omphalomesenteric duct anomalies, congenital heart disease (such as ventricular septal defect), renal system malformations and aplasia cutis. Additional features that may be observed include facial dysmorphism (short up slanting palpebral fissures, a broad nasal bridge with a small nose and a broad forehead) and athelia. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Embryofetopathy caused by methimazole (disorder) Pathological process (attribute) Pathological developmental process true Inferred relationship Some 1
Embryofetopathy caused by methimazole (disorder) morphologie associée (attribut) structure anormale sur le plan morphologique true Inferred relationship Some 1
Embryofetopathy caused by methimazole (disorder) est un(e) (attribut) Congenital malformation syndrome (disorder) true Inferred relationship Some
Embryofetopathy caused by methimazole (disorder) est un(e) (attribut) trouble selon la localisation corporelle false Inferred relationship Some
Embryofetopathy caused by methimazole (disorder) est un(e) (attribut) Drug-related disorder false Inferred relationship Some
Embryofetopathy caused by methimazole (disorder) est un(e) (attribut) Congenital malformation syndrome due to known exogenous cause false Inferred relationship Some
Embryofetopathy caused by methimazole (disorder) est un(e) (attribut) Disorder of fetal structure false Inferred relationship Some
Embryofetopathy caused by methimazole (disorder) morphologie associée (attribut) Developmental abnormality false Inferred relationship Some 1
Embryofetopathy caused by methimazole (disorder) Causative agent Methimazole true Inferred relationship Some 1
Embryofetopathy caused by methimazole (disorder) survenue (attribut) congénital true Inferred relationship Some 1
Embryofetopathy caused by methimazole (disorder) localisation d'une constatation (attribut) Fetal structure true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start